Filing search / Inhibrx Biosciences, Inc. / "Innovative"

8-K

EX-99.1

INBX Inhibrx Biosciences, Inc.

24 May 24

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

4:08pm

. For more information, please visit www.inhibrx.com. About Sanofi Sanofi is an innovative global healthcare company, driven by one purpose: chase

8-K

EX-99.1

INBX Inhibrx Biosciences, Inc.

8 May 24

Other Events

4:42pm

information, please visit www.inhibrx.com. About Sanofi Sanofi is an innovative global healthcare company, driven by one purpose: chase the miracles

8-K

EX-99.1

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

proprietary protein engineering platforms. For more information, please visit www.inhibrx.com. About Sanofi Sanofi is an innovative global healthcare

8-K

EX-99.2

fumn0m

7 Aug 23

Inhibrx Reports Second Quarter 2023 Financial Results

4:05pm

8-K

EX-99.1

wwnp7lb42smqoew

28 Oct 21

Departure of Directors or Certain Officers

8:50am

8-K

EX-99.2

0shh6hc9t

12 Mar 21

Results of Operations and Financial Condition

8:55am

10-K

88p22l4btdx

12 Mar 21

Annual report

8:46am

8-K

EX-99.2

m2qij8tmh gaqrk84

5 Jan 21

Inhibrx Announces Phase 1 Dose Escalation Results of

12:00am

10-Q

9j05a

13 Nov 20

Quarterly report

4:09pm

8-K

EX-99.2

adcjmy6xrzgdgv2zzl

12 Nov 20

Inhibrx Announces Positive Interim Results from the Phase 1 Trial of INBRX-109 in Chondrosarcoma Patients

6:07am

8-K

EX-99.1

pg4h39zbafp4pm

11 Sep 20

Regulation FD Disclosure

4:24pm